Substance / Medication

Interferon alfacon-1

Overview

Active Ingredient
interferon alfacon-1
RxNorm CUI
59744

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Clinical Trials

190 trials linked to this intervention

190
Total Trials
21
Recruiting
76
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Extrahepatic Manifestations of Hepatitis C: A Meta-analysis of Prevalence, Quality of Life, and Economic Burden.
Younossi Zobair, Park Haesuk, Henry Linda et al. · Gastroenterology · 2016
PMID: 26924097Meta-Analysis
Non HCV-related infectious cryoglobulinemia vasculitis: Results from the French nationwide CryoVas survey and systematic review of the literature.
Terrier Benjamin, Marie Isabelle, Lacraz Adeline et al. · J Autoimmun · 2015
PMID: 26320984Meta-Analysis
Treatment for cryoglobulinemic and non-cryoglobulinemic peripheral neuropathy associated with hepatitis C virus infection.
Benstead Tim J, Chalk Colin H, Parks Natalie E · Cochrane Database Syst Rev · 2014
PMID: 25525951Meta-AnalysisFull text (PMC)
Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn's disease.
Canavan C, Abrams K R, Mayberry J · Aliment Pharmacol Ther · 2006
PMID: 16611269Meta-Analysis
ENETS Consensus Guidelines Update for Neuroendocrine Neoplasms of the Jejunum and Ileum.
Niederle B, Pape U-F, Costa F et al. · Neuroendocrinology · 2016
PMID: 26758972Review
Colonic polypectomy (with videos).
Burgess Nicholas G, Bahin Farzan F, Bourke Michael J · Gastrointest Endosc · 2015
PMID: 25805461Review
Retreating chronic hepatitis C with daily interferon alfacon-1/ribavirin after nonresponse to pegylated interferon/ribavirin: DIRECT results.
Bacon Bruce R, Shiffman Mitchell L, Mendes Flavia et al. · Hepatology · 2009
PMID: 19291790Trial
[Study of the efficacy of combined therapy with interferon alfacon-1 and ribavirin for chronic hepatitis C].
Horban Andrzej, Wasilewski Marek, Berak Hanna et al. · Przegl Epidemiol · 2006
PMID: 17249181Trial
Interferon alfacon-1 and ribavirin versus interferon alpha-2b and ribavirin in the treatment of chronic hepatitis C.
Sjogren Maria H, Sjogren Robert, Holtzmuller Kent et al. · Dig Dis Sci · 2005
PMID: 15844709Trial

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Health Goals

Goals connected through associated conditions

Quick Facts

Type
Substance / Medication
Fully Specified Name
Interferon alfacon-1 (substance)
SNOMED CT
108745009
UMLS CUI
C0164613
RxNorm CUI
59744

Clinical Data

This intervention maps to 26 entities in the Ltrl knowledge graph.

20
Conditions
3
Biomarkers
2
Specialists
0
Symptoms
190
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.

Interferon alfacon-1: Uses, Evidence & Side Effects | Ltrl